Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

90-minute British DnaNudge COVID-19 test is accurate, Lancet study finds

Published 18/09/2020, 07:02
Updated 18/09/2020, 11:15
© Reuters. FILE PHOTO: People queue outside a test centre in Southend-on-sea

LONDON (Reuters) - A British COVID-19 test known as DnaNudge that gives results in just over an hour and which requires no laboratory was accurate in almost all cases, an academic review in the Lancet has found.

Faster testing could allow more people to return to work or permit testing on entry to hospital, thus slowing a second spike in coronavirus infections.

The new test, based on the design of a DNA test developed by a professor at Imperial College London, received approval for clinical use by the Medicines and Healthcare Products Regulatory Agency (MHRA) at the end of April after successful trials.

In a study in The Lancet Microbe, the test was found to have an average sensitivity – the ability to correctly identify those with COVID-19 – of 94.4% and a specificity – correctly identifying those without the disease – of 100%.

"These results suggest that the CovidNudge test, which can be performed at a patient’s bedside without the need to handle any sample material, has comparable accuracy to standard laboratory testing," Professor Graham Cooke, lead author of the study from the Department of Infectious Disease at Imperial College London, said.

The Lancet paper described the test, which requires one nostril swab, as "a sensitive, specific, and rapid point of care test for the presence of SARS-CoV-2 without laboratory handling or sample pre-processing".

Health Secretary Matt Hancock told LBC radio that Britain was rolling out the tests across hospitals.

"The critical thing in terms of usefulness is that the machine doesn't need to be in a lab - it is about the size of a shoebox - therefore you can put one, say, in an A&E (accident and emergency) department and they can know whether people coming in have got the coronavirus or not," Hancock said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Hancock said the machines could also be deployed at other locations such as schools.

Each box can run one test at a time so could process about 16 tests per day, said a spokeswoman for the company that produces the tests.

For the text of the Lancet paper: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30121-X/fulltext

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.